Belimumab Intravenous and Signifor (Pasireotide Extended-Release Injection)
Determining the interaction of Belimumab Intravenous and Signifor (Pasireotide Extended-Release Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: belimumab
Brand name: Benlysta, Benlysta Autoinjector
Synonyms: Belimumab
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Belimumab Intravenous-Signifor (Pasireotide Injection)
- Belimumab Intravenous-Signifor Injection
- Belimumab Intravenous-Signifor LAR
- Belimumab Intravenous-Signifor LAR Injection
- Belimumab Intravenous-Siklos
- Belimumab Intravenous-Siladryl Allergy
- Signifor (Pasireotide Extended-Release Injection)-Belimumab Vials
- Signifor (Pasireotide Extended-Release Injection)-Belinostat
- Signifor (Pasireotide Extended-Release Injection)-Belinostat Intravenous
- Signifor (Pasireotide Extended-Release Injection)-Belladonna
- Signifor (Pasireotide Extended-Release Injection)-Belladonna alkaloids and phenobarbital
- Signifor (Pasireotide Extended-Release Injection)-Belladonna and Opium